Kraig Biocraft Laboratories to Hold Shareholder Conference Call to Discuss Laboratory, Technical and Commercialization Updates
May 25 2011 - 6:05AM
Marketwired
Kraig Biocraft Laboratories, Inc. (PINKSHEETS: KBLB) announces
today that Kim Thompson cordially invites all interested parties to
participate in the Company's conference call to be held on Friday,
June 10, 2011 at 4:30 p.m. EDT.
Thompson, the Company's CEO and Founder, will review the recent
Sigma-Aldrich agreement and upcoming laboratory developments, as
well as what is in the recombinant spider silk commercialization
pipeline, followed by a question and answer period.
The conference call phone number and other details, including
access codes, will be announced in a follow-up company release on
the morning of the call. Shareholders are invited to submit
questions to benh@ttfsco.com and must be received by Thursday, June
9, to be considered.
About Kraig Biocraft Laboratories
Kraig Biocraft Laboratories is a fully reporting biotechnology
company that recently achieved a series of scientific
breakthroughs, with implications for the global textile industry.
For further information please visit www.KraigLabs.com.
Statements in this press release about the Company's future and
expectations other than historical facts are "forward-looking
statements." These statements are made on the basis of management's
current views and assumptions. As a result, there can be no
assurance that management's expectations will necessarily come to
pass. These forward-looking statements generally can be identified
by phrases such as "believes," "plans," "expects," "anticipates,"
"foresees," "hopes," "develops," "researching," "research,"
"potential," "could" or other words or phrases of similar import.
Similarly, statements in this release that describe the Company's
business strategy, outlook, objectives, plans, intentions or goals
should all be considered forward-looking statements. All such
forward-looking statements are subject to certain risks and
uncertainties that could cause actual results to differ materially
from those in forward-looking statements. Management cautions that
its ability to further its research, and create commercially-viable
products may be affected by the competitive environment, the
Company's financial condition and its ability to raise sufficient
capital to meet the financial obligations of its business plan and
to fund its continuing operations.
Contact: Ben Hansel (720) 288-8495 Email Contact
Kraig Biocraft Laborator... (QB) (USOTC:KBLB)
Historical Stock Chart
From May 2024 to Jun 2024
Kraig Biocraft Laborator... (QB) (USOTC:KBLB)
Historical Stock Chart
From Jun 2023 to Jun 2024